Comparison of IL-10 and MCP-1-7ND gene transfer with AAV9 vectors for protection from murine autoimmune myocarditis

Cardiovascular Research

Volumn 91, Issue 1, 2011, Pages 116-123

  Kaya, Ziya ^a   Leib, Christoph ^a   Werfel, Stanislas ^a   Göser, Stefan ^a   Öttl, Renate ^a   Leuchs, Barbara ^b   Pfitzer, Gabriele ^c   Katus, Hugo A ^a   Müller, Oliver J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adeno associated virus; Gene therapy; Myocarditis; Troponin I

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CYTOKINE; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR; PARVOVIRUS VECTOR; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE FIBROSIS; MOUSE; MYOCARDITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; T LYMPHOCYTE ACTIVATION; VIRUS EXPRESSION; VIRUS TRANSCRIPTION;

ANIMALS; AUTOIMMUNE DISEASES; CHEMOKINE CCL2; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNITY, HUMORAL; INJECTIONS, INTRAVENOUS; INTERLEUKIN-10; MICE; MYOCARDITIS; MYOCARDIUM; RECEPTORS, CHEMOKINE; TIME FACTORS; TRANSCRIPTION, GENETIC; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 79958794349     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr063     Document Type: Article

References (39)

1. Fairweather D, Rose NR. Inflammatory heart disease: a role for cytokines. Lupus 2005; 14:646-651. (Pubitemid 41413283)
2. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008;226:205-218.
3. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990;248:1230-1234.
4. Nakano A, Matsumori A, Kawamoto S, Tahara H, Yamato E, Sasayama S et al. Cytokine gene therapy for myocarditis by in vivo electroporation. Hum Gene Ther 2001;12: 1289-1297. (Pubitemid 32681843)
5. Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999;100:1102-1108. (Pubitemid 29416237)
6. Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F et al. Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol 2002;168:1552-1556. (Pubitemid 34135748)
7. Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S et al. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology 2000;119: 1461-1472. (Pubitemid 32198671)
8. van Deventer SJ, Elson CO, Fedorak RN. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 1997;113:383-389. (Pubitemid 27351761)
9. Cua DJ, Hutchins B, LaFace DM, Stohlman SA, Coffman RL. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J Immunol 2001;166: 602-608. (Pubitemid 32038483)
10. Dawson J, Miltz W, Mir AK, Wiessner C. Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 2003;7:35-48. (Pubitemid 36204587)
11. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009;29:313-326.
12. Damas JK, Aukrust P, Ueland T, Odegaard A, Eiken HG, Gullestad L et al. Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes. Basic Res Cardiol 2001;96: 345-352. (Pubitemid 32700571)
13. Kolattukudy PE, Quach T, Bergese S, Breckenridge S, Hensley J, Altschuld R et al. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol 1998;152:101-111. (Pubitemid 28028051)
14. Matsumori A, Furukawa Y, Hashimoto T, Yoshida A, Ono K, Shioi T et al. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997;29:419-423. (Pubitemid 27129164)
15. Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, Lindsey ML et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 1997;95:693-700. (Pubitemid 27063047)
16. Zhang YJ, Rutledge BJ, Rollins BJ. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J Biol Chem 1994;269: 15918-15924.
17. Göser S,Öttl R, Brodner A, Dengler TJ, Torzewski J, Egashira K et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 2005;112:3400-3407. (Pubitemid 43739554)
18. Müller OJ, Katus HA, Bekeredjian R. Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 2007;73:453-462. (Pubitemid 46084926)
19. Jiang H, Pierce GF, Ozelo MC, de Paula EV, Vargas JA, Smith P et al. Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B. Mol Ther 2006;14:452-455. (Pubitemid 44184967)
20. Chu D, Sullivan CC, Weitzman MD, Du L, Wolf PL, Jamieson SW et al. Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. J Thorac Cardiovasc Surg 2003; 126:671-679. (Pubitemid 37151949)
21. Prasad KM, Xu Y, Yang Z, Acton ST, French BA. Robust cardiomyocyte- specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 2010;18:43-52.
22. Inagaki K, Fuess S, Storm TA, Gibson GA, Mctiernan CF, Kay MA et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther 2006;14:45-53. (Pubitemid 43899488)
23. Nakai H, Fuess S, Storm TA, Muramatsu S, Nara Y, Kay MA. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J Virol 2005;79: 214-224. (Pubitemid 39650967)
24. Pacak CA, Mah CS, Thattaliyath BD, Conlon TJ, Lewis MA, Cloutier DE et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res 2006;99:e3-e9. (Pubitemid 44255502)
25. Müller OJ, Leuchs B, Pleger ST, Grimm D, Franz WM, Katus HA et al. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovasc Res 2006;70:70-78.
26. Müller OJ, Schinkel S, Kleinschmidt JA, Katus HA, Bekeredjian R. Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats. Gene Ther 2008;15:1558-1565.
27. Krüger M, Pfitzer G, Stehle R. Expression and purification of human cardiac troponin subunits and their functional incorporation into isolated cardiac mouse myofibrils. J Chromatogr B Analyt Technol Biomed Life Sci 2003;786:287-296. (Pubitemid 36324585)
28. al-Hillawi E, Minchin SD, Trayer IP. Overexpression of human cardiac troponin-I and troponin-C in Escherichia coli and their purification and characterisation. Two point mutations allow high-level expression of troponin-I. Eur J Biochem 1994;225: 1195-1201. (Pubitemid 24342566)
29. Göser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Öttl R et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006;114:1693-1702. (Pubitemid 44607117)
30. Kaya Z, Göser S, Buss SJ, Leuschner F, Öttl R, Li J et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008;118:2063-2072.
31. Furukawa Y, Kobuke K, Matsumori A. Role of cytokines in autoimmune myocarditis and cardiomyopathy. Autoimmunity 2001;34:165-168. (Pubitemid 34149806)
32. Watanabe K, Nakazawa M, Fuse K, Hanawa H, Kodama M, Aizawa Y et al. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001;104:1098-1100. (Pubitemid 32830390)
33. Kaur K, Dhingra S, Slezak J, Sharma AK, Bajaj A, Singal PK. Biology of TNFalpha and IL-10, and their imbalance in heart failure. Heart Fail Rev 2009;14:113-123.
34. Chang H, Hanawa H, Yoshida T, Hayashi M, Liu H, Ding L et al. Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transfer. Circ J 2008;72:813-819. (Pubitemid 351716688)
35. Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP et al. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 2003;107:320-325. (Pubitemid 36135231)
36. Vassalli G, Bueler H, Dudler J, von Segesser LK, Kappenberger L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int J Cardiol 2003; 90:229-238. (Pubitemid 37087882)
37. Bish LT, Morine K, Sleeper MM, Sanmiguel J, Wu D, Gao G et al. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther 2008;19:1359-1368.
38. Ying Y, Müller OJ, Goehringer C, Leuchs B, Trepel M, Katus HA et al. Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library. Gene Ther 2010;17:980-990.
39. Raake PW, Hinkel R, Müller S, Delker S, Kreuzpointner R, Kupatt C et al. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther 2008;15:12-17. (Pubitemid 350284205)